Achieve Life Sciences
ACHV
16 hedge funds and large institutions have $3.99M invested in Achieve Life Sciences in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
23% more funds holding
Funds holding: 13 → 16 (+3)
5% more capital invested
Capital invested by funds: $3.79M → $3.99M (+$205K)
1.01% more ownership
Funds ownership: 12.61% → 13.62% (+1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$344K |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$233K |
| 3 |
Millennium Management
New York
|
+$169K |
| 4 |
Goldman Sachs
New York
|
+$91.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Requisite Capital Management
Dallas,
Texas
|
-$419K |
| 2 |
Morgan Stanley
New York
|
-$135K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$126K |
| 4 |
Squarepoint
New York
|
-$84K |
| 5 |
NNP
Nachman Norwood & Parrott
Greenville,
South Carolina
|
-$1K |
ACHV Hedge Fund Activity: Q4 2020 in Review
16 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2020, worth a combined $3.99M — up 5.4% from $3.79M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ACHV positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Perkins Capital Management, opening a new position worth an estimated $344K. The largest seller was Requisite Capital Management, exiting entirely with an estimated $419K sold.
- 16 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2020, up from 13 in Q3 2020.
- Funds reported $3.99M of Achieve Life Sciences stock for Q4 2020, up 5.4% quarter-over-quarter.
- 6 funds opened new Achieve Life Sciences positions in Q4 2020 and 3 closed out, a net change of +3 holders.
- The largest Achieve Life Sciences buyer in Q4 2020 was Perkins Capital Management, an estimated $344K added.
- The largest Achieve Life Sciences seller in Q4 2020 was Requisite Capital Management, an estimated $419K sold.
Based on aggregated 13F filings for Q4 2020.